Novel Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Favorable Druggability
Tong Zhao(China Pharmaceutical University), Peng Zhan(Shandong University of Traditional Chinese Medicine), Ruipeng Liang(Shandong University), Xinyong Liu(Shandong University of Traditional Chinese Medicine), Yue Dong(Peking University), Wei Ai, Ting Wu(Huazhong Agricultural University), Zhuosen Sun(Shandong University), Dongwei Kang(Shandong University), Qing Meng, Yanyu Chen(Harbin University of Commerce), Jianxin Pang(Southern Medical University), Zean Zhao(University of Science and Technology of China)
Cited by 58
Related Papers
Overview of Recent Strategic Advances in Medicinal Chemistry
|Journal of Medicinal Chemistry|2019|181
3D-QSAR and docking studies of flavonoids as potent Escherichia coli inhibitors
|Scientific Reports|2016|111
Identification of Dihydrofuro[3,4-<i>d</i>]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties
|Journal of Medicinal Chemistry|2019|87
Cumulus Cells Accelerate Aging of Mouse Oocytes1
|Biology of Reproduction|2005|82
Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles
|Journal of Medicinal Chemistry|2019|77